Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where H. G. Muchmore is active.

Publication


Featured researches published by H. G. Muchmore.


Journal of Clinical Immunology | 1988

Operation Everest II: Alterations in the immune system at high altitudes

Richard T. Meehan; Ulric Duncan; Laureen S. Neale; Gerald Taylor; H. G. Muchmore; Nan Scott; Keith M. Ramsey; Eric M. Smith; Paul B. Rock; Randall M. Goldblum; Charles Houston

We investigated the effects on immune function after progressive hypobaric hypoxia simulating an ascent to 25,000 ft (7620 m) over 4 weeks. Multiple simultaneousin vitro andin vivo immunologic variables were obtained from subjects at sea level, 7500 ft (2286 m), and 25,000 ft during a decompression chamber exposure. Phytohemag-glutinin-stimulated thymidine uptake and protein synthesis in mononuclear cells were reduced at extreme altitudes. Mononuclear-cell subset analysis by flow cytometry disclosed an increase in monocytes without changes in B cells or T-cell subsets. Plasma IgM and IgA but not IgG levels were increased at altitudes, whereas pokeweed mitogen-stimulatedin vitro IgG, IgA, and IgM secretion was unchanged. During exposure to 25,000 ft,in vitro phytohemagglutinin-stimulated interferon production and natural killer-cell cytotoxicity did not change statistically, but larger intersubject differences occurred. IgA and lysozyme levels (nasal wash) and serum antibodies to nuclear antigens were not influenced by altitude exposure. These results suggest that T-cell activation is blunted during exposure to severe hypoxemia, whereas B-cell function and mucosal immunity are not. Although the mechanism of alteredin vitro immune responsiveness after exposure to various environmental stressors has not been elucidated in humans, hypoxia may induce alterations in immune regulation as suggested byin vitro immune assays of effector-cell function.


Medical Mycology | 1981

Enzyme-linked immunosorbent assays in murine cryptococcosis

E. Nan Scott; H. G. Muchmore; Frances G. Felton

In this investigation, enzyme-linked immunosorbent assay (ElISA) procedures were used to study the time of appearance and the duration of demonstrable antigen and antibody in body fluids of mice with disseminated cryptococcosis. The ELISA antigen procedure detected cryptococcal capsular polysaccharide (CCP) in the serum and urine of infected mice 3 days after infection--4 days before it could be demonstrated by the latex agglutination procedure. ELISA-reactive antibody was present throughout the course of infection (mean death time, 32 days), whereas antibody was not detected by whole cell agglutination after day 20. High serum concentrations of CCP (titers to 64,000) persisted throughout the course of infection, while antibody declined to low levels with progression of disease. ELISA provides a sensitive system for quantitation and monitoring of antigen (CCP) processing and clearance (or storage), and for cryptococcal antibody formation in progressive cryptococcosis.


Medical Mycology | 1968

Delayed hypersensitivity to cryptococcin in man

H. G. Muchmore; Frances G. Felton; S.B. Salvin; Everett R. Rhoades

Twenty-six of 82 healthy persons from a small community in Oklahoma responded to intradermal testing with cryptococcin by development of typical delayed skin reactions with induration of 5 mm. or greater in diameter. Although the hyper-reactivity to cryptococcin may be due to past exposure to C. neoformans, exact interpretation of the observed reactions cannot be definite at this time because of concomitant presence of histoplasmin sensitivity in some of the subjects tested.


Analytical Biochemistry | 1981

Purification of labeled antibody by minicolumn gel centrifugation

Alan J. Parkinson; E.N. Scott; H. G. Muchmore

Radiolabeled anti-human immunoglobulin G was purified by the elution from a minicolumn of Protein A-Sepharose by gel centrifugation. As much as 93.7% of the Protein A-bound 125I-labeled immunoglobulin G was recovered within the first three 200-μl fractions. Removal of the eluting agent was achieved by centrifuging the peak fractions through a minicolumn of hydrated Sephadex G-50.


Medical Mycology | 1969

Cell wall differences of patient and soil isolates of Cryptococcus neoformans

W.L. Cook; Frances G. Felton; H. G. Muchmore; E.R. Rhoades

Two isolates of Cryptococcus neoformans were studied to determine whether or not differences in chemical composition of the cell walls existed. Aerated cultures of both isolates were grown at 37°C. in a synthetic liquid medium. A purified cell wall fraction was obtained by repeated passage of cells through a French pressure cell followed by differential centrifugation. Chemical analyses of cell wall fractions of each of these strains showed quantitative differences in 3 major groups of compounds. The isolate from the patient contained a higher percentage of hexose and a lower percentage of hexosamines and lipids than did the soil isolate.


Nature | 1981

Persistent parainfluenza virus shedding during isolation at the South Pole

H. G. Muchmore; Alan J. Parkinson; Joe E. Humphries; E. Nan Scott; Douglas A. McIntosh; L. Vernon Scott; Marion K. Cooney; John A. R. Miles


American Journal of Epidemiology | 1980

CRYPTOCOCCUS NEOFORMANS SEROTYPE GROUPS ENCOUNTERED IN OKLAHOMA

H. G. Muchmore; E. Nan Scott; Frances G. Felton; Robert A. Fromtling


American Journal of Epidemiology | 1980

SEROLOGIC EVIDENCE FOR PARAINFLUENZAVIRUS INFECTION DURING ISOLATION AT SOUTH POLE STATION, ANTARCTICA

Alan J. Parkinson; H. G. Muchmore; T. A. McCONNELL; L. V. Scott; J. A. R. Miles


The Journal of Infectious Diseases | 1970

The Effect of Cryptococcin on Leukocytic Migration

John A. Mohr; H. G. Muchmore; Frances G. Felton; Everett R. Rhoades; Beverly A. McKown


The American review of respiratory disease | 1966

Experimental cryptococcal infection in rabbits.

Frances G. Felton; W. E. Maldonado; H. G. Muchmore; Everett R. Rhoades

Collaboration


Dive into the H. G. Muchmore's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

L. V. Scott

University of Oklahoma

View shared research outputs
Top Co-Authors

Avatar

E.N. Scott

University of Oklahoma

View shared research outputs
Top Co-Authors

Avatar

S.B. Salvin

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

E.R. Rhoades

United States Department of Veterans Affairs

View shared research outputs
Top Co-Authors

Avatar

Eric M. Smith

University of Texas Medical Branch

View shared research outputs
Researchain Logo
Decentralizing Knowledge